Drug Discovery Informatics Market to 2022 - Dominated by IBM (US), Infosys (India), Schrodinger (US) and Thermo Fisher Scientific (US)

Press Release   •   Jan 22, 2018 05:59 EST

Key players in drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the global market.

Download the Sample Copy of Drug Discovery Informatics Market spread across 115 Pages, Profiling 15 Companies and Supported with 63 Tables and 24 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1274076 .

The global drug discovery informatics market is projected to reach USD 2.84 Billion in 2022 from USD 1.50 Billion in 2016, at CAGR of 11.2% during forecast period. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022. In the current market scenario, there is a growing demand for discovery informatics solutions.

Target Audience:

  • Providers drug discovery informatics solution
  • Pharmaceutical companies
  • Academic institutes
  • Biotechnology companies
  • Research institutes
  • Government associations
  • Contract research organizations (CROs)

The drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market.

Click here for more information on this research report now at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1274076 .

North America is expected to account for the largest share of the global drug discovery informatics market. Asia Pacific is expected to register the highest growth rate from 2017 to 2022. This can be attributed to the fastest-growing APAC pharmaceutical market in the world, the availability of many qualified researchers, and the low cost of human resources and manufacturing.

Competitive Landscape

  • Overview
  • Ranking of Players, 2016
  • Competitive Scenario
  • Collaborations, Partnerships, Agreements, & Acquisitions
  • Expansions
  • Product Launches & Enhancements

Click now for more Details, Queries, Other Information and Corporate Discount on this study “Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022” report @ http://www.rnrmarketresearch.com/contacts/discount?rname=1274076 .

Drug discovery informatics market in this report is segmented by function, solution, end user, and region. Study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the drug discovery informatics market.

Drug Discovery Informatics Market, By Function

  • Introduction
  • Sequencing & Target Data Analysis
  • Docking
  • Molecular Modelling
  • Libraries & Database Preparation

Drug Discovery Informatics Market, By End User

  • Introduction
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROS)

The largest share of this segment is attributed to the fast and efficient management of data generated throughout the drug discovery process using discovery informatics software solutions.

Contact sales@rnrmarketresearch.com/ Call +1 888 391 5441 for further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.

Market research studies several features of business environment, such as competitors, market structure, government regulations, economic trends, technological advances and financial analysis of companies, industries, and sectors.